Anemia, blood transfusion requirements and mortality risk in human immunodeficiency virus-infected adults requiring acute medical admission to hospital in South Africa

Open Forum Infectious Diseases

Volumn 2, Issue 4, 2015, Pages

  Kerkhoff, Andrew D ^a,b,c   Lawn, Stephen D ^c,d   Schutz, Charlotte ^c   Burton, Rosie ^c,e   Boulle, Andrew ^c,f   Cobelens, Frank J ^b,g   Meintjes, Graeme ^c,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Khayelitsha Hospital   (South Africa)

^f WESTERN CAPE DEPARTMENT OF AGRICULTURE   (South Africa)

^g KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Africa; AIDS; Anemia; Blood transfusion; HIV; Hospitalized; Mortality

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; COMORBIDITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MORTALITY RISK; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS LOAD;

EID: 85014136901     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv173     Document Type: Article

References (41)

1. Akinkuotu A, Roemer E, Richardson A, et al. In-hospital mortality rates and HIV: a medical ward review, Lilongwe, Malawi. Int J STD AIDS 2011; 22:465-70.
2. Lewden C, Drabo JY, Zannou MD, et al. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era. J Int AIDS Soc 2014; 17:1-12.
3. Johannessen A, Naman E, Gundersen SG, Bruun JN. Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infect Dis 2011; 11:190.
4. O'Brien ME, Kupka R, Msamanga GI, et al. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr 2005; 40:219-25.
5. KerkhoffAD, Wood R, Cobelens FG, et al. Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa. BMC Infect Dis 2014; 14:702.
6. Parrish DD, Blevins M, Megazzini KM, et al. Haemoglobin recovery among HIV-1 infected patients on zidovudine-based antiretroviral therapy and other regimens in north-central Nigeria. Int J STD AIDS 2014; 25:355-9.
7. Volberding P. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis 2002; 185:S110-4.
8. Harris RJ, Sterne JA, Abgrall S, et al. Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther 2007; 13:959-67.
9. Johannessen A, Naman E, Ngowi BJ, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 2008; 8:52.
10. Russell EC, Charalambous S, Pemba L, et al. Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study. BMC Public Health 2010; 10:433.
11. Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr 1998; 19:29-33.
12. Van den Berg K, Van Hasselt J, Bloch E, et al. A review of the use of blood and blood products in HIV-infected patients: review. S Afr HIV Med 2012; 13:87-103.
13. Moore RD, Forney D. Anemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 29:54-7.
14. Takuva S, Maskew M, Brennan AT, et al. Anemia among HIV-infected patients initiating antiretroviral therapy in South Africa: improvement in hemoglobin regardless of degree of immunosuppression and the initiating ART regimen. J Trop Med 2013; 2013:1-6.
15. van den Berg K, Murphy EL, Pretorius L, Louw VJ. The impact of HIVassociated anaemia on the incidence of red blood cell transfusion: Implications for blood services in HIV-endemic countries. Transfus Apher Sci 2014; 51:10-8.
16. Ntusi NBA, Sonderup MW. HIV/AIDS influences blood and blood product use at Groote Schuur Hospital, Cape Town. S Afr Med J 2011; 101:463-6.
17. Butler EK, Hume H, Birungi I, et al. Blood utilization at a national referral hospital in sub-Saharan Africa. Transfusion 2015; 55:1058-66.
18. Vamvakas E, Kaplan HS. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 1993; 33: 111-8.
19. Buskin SE, Sullivan PS. Anemia and its treatment and outcomes in persons infected with human immunodeficiency virus. Transfusion 2004; 44:826-32.
20. Mudido PM, Georges D, Dorazio D, et al. Human immunodeficiency virus type 1 activation after blood transfusion. Transfusion 1996; 36:860-5.
21. Gupta A, Wood R, Kaplan R, et al. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. PLoS One 2013; 8:e55824.
22. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20:1605-12.
23. Lawn SD, KerkhoffAD, Burton R, et al. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa. BMC Med 2015; 13:192.
24. Meintjes G, KerkhoffAD, Burton R, et al. HIV-Related Medical Admissions to a South African District Hospital Remain Frequent Despite Effective Antiretroviral Therapy Scale-Up. Medicine (Baltimore); 2015; 94:e2269.
25. World Health Organization. Haemoglobin concentrations for the diagnosis of anemia and assessment of severity. Geneva; 2011. Available at: http://www.who.int/iris/bitstream/10665/85839/http://apps.who.int//iris/bitstream/10665/85839/3/WHO_NMH_NHD_MNM_11.1_eng. pdf?ua=1. Accessed: 07/27/2015.
26. National Institutes of Health. Division of AIDS table for grading the severity of adult and pediatric adverse events, version 1.0. 2009 :1-21. Available at: http://rsc.tech-res.com/document/safetyandpharmaco vigilance/table_for_grading_severity_of_adult_pediatric_adverse_events. pdf. Accessed: 27 July 2015.
27. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145:247-54.
28. Hillyer CD, Lankford KV, Roback JD, et al. Transfusion of the HIVseropositive patient: immunomodulation, viral reactivation, and limiting exposure to EBV (HHV-4), CMV (HHV-5), and HHV-6, 7, and 8. Transfus Med Rev 1999; 13:1-17.
29. Collier AC, Kalish LA, Busch MP, et al. Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the viral activation transfusion study: a randomized controlled trial. JAMA 2001; 285:1592-601.
30. McDermid JM, Jaye A, Schim van der LoeffMF, et al. Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr 2007; 46:498-507.
31. Psaty BM, Koepsell TD, Lin D, et al. Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc 1999; 47:749-54.
32. Lewis DK, Whitty CJ, Walsh AL, et al. Treatable factors associated with severe anaemia in adults admitted to medical wards in Blantyre, Malawi, an area of high HIV seroprevalence. Trans R Soc Trop Med Hyg 2005; 99:561-7.
33. KerkhoffAD, Wood R, Vogt M, Lawn SD. Predictive value of anemia for tuberculosis in HIV-infected patients in sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays. J Acquir Immune Defic Syndr 2014; 66:33-40.
34. Masaisa F, Gahutu JB, Mukiibi J, et al. Anemia in human immunodeficiency virus-infected and uninfected women in Rwanda. Am J Trop Med Hyg 2011; 84:456-60.
35. KerkhoffAD, Wood R, Cobelens FG, et al. The predictive value of current haemoglobin levels for incident tuberculosis and/or mortality during long-term antiretroviral therapy in South Africa: a cohort study. BMC Med 2015; 13:e1001270-24.
36. Opie J. Haematological complications of HIV infection. S Afr Med J 2012; 102:465-8.
37. Osaro E, Adias T. The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood. J Blood Med 2011; 2:7-21.
38. Ogunbanjo G. Are there alternatives to the shortage of blood in South Africa? S Afr Fam Pract 2014; 56:i-i.
39. Lara AM, Kandulu J, Chisuwo L, et al. Laboratory costs of a hospitalbased blood transfusion service in Malawi. J Clin Path 2007; 60:1117-20.
40. Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 2001; 135:17-26.
41. Ifland L. Promoting national blood systems in developing countries. Curr Opin Hematol 2014; 21:497-502.